Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions.
暂无分享，去创建一个
C. Dash | S. Khakoo | I. Murray-Lyon | P. Glue | G. Dusheiko | L. Grellier | B. Flannery | A. Bell | B. Wells | D. Lypnyj | K. Walters | I. Murray-Lyon | Karen Walters | Beverley Wells | Allan Bell | Clive Dash | David Lypnyj